Suchergebnisse

Bu çalışma nezaket ifadelerinin, dildeki yansımalarını ortaya çıkarmayı hedeflemektedir. Nezaket algısı çok yönlü bir algı olmakla birlikte, en ilkel kabileden en gelişmiş topluluğa kadar kendine has nezaket durumları veya ifadeleriyle kendini hissettirmektedir. Nezaketin, konuşmanın seyrini olumlu veya olumsuz olarak etkilediği gerçeği yadsınamamaktadır. Bir ifadenin nezaket değeri aslında o ifadenin anlam değerinde de önemli bir rol oynadığı bilinmektedir. Nezaket, yazılı bir kural değildir; fakat bu yazısız olan davranışlar, toplumlarda en az yazılı kurallar kadar önem arz etmektedir. Birtakım nezaket, görgü kurallarınca hareket etmek toplumdaki konumumuza da doğrudan etki edebilmektedir. Bunların yapılmaması sonucunda bir yaptırım cezası ile karşı karşıya kalınmasa bile toplum tarafından dışlanılması, kabul görülmemesine sebebiyet verebilmektedir. Tersi halinde ise nezaket, ahlak sahibi kişilerin de o toplumda yüceltilebileceği görülmektedir. Yaşamımızın her alanında önemli bir kavram olan nezaket, günlük hayatta ilişkilerimizi düzenleyen önemli ve gerekli bir unsur olarak görülmektedir. Bundan dolayı, bu önemli unsurun Türkçenin eski şivelerinden olan eski Uygur Türkçesindeki görünümünün ortaya koyulması amaçlanmıştır. Bu konunun Türkçenin eski dönemlerinde de nasıl işlendiğini görmek adına, eski Uygur Türkçesi şivesine ait olan "Aç Bars" hikâyesi örnekleminde açıklanmaya çalışılmıştır. Bu eser örnekleminden hareketle, yazılı dildeki nezaket incelemesi, Brown ve Levinson'a ait olan bir nezaket kuramı yöntemi ile incelenmeye çalışılmıştır. Bu kuramın seçilmesindeki ana sebep ise birbirinden farklı ve uzak üç dil (Tzeltal dili, Tamil dili ve İngiliz dili) üzerinden oluşturulmuş olmasıdır. Bu birbirinden uzak üç dilde dahi ortak olgular bulunması ve çok farklılıklar görülmemesi, nezaketin evrenselliği noktasında önemli tespitler içermektedir.

AbstractDespite being in existence for many decades, normative decision theory has not become a commonly used tool for real‐world decisions. This paper considers the reasons for this situation and suggestions for circumventing them. The main suggestion involves a two‐stage framework in terms of the information available to the decision maker and his/her expectations under the available acts. This framework is well suited for decisions with incomplete structure, which is typical of real decision situations. Within this framework a specific multiplicative model is also discussed.

PubMedID: 28151863 ; The aim of this study was to determine the clinical features, and outcome of the patients with miliary tuberculosis (TB). We retrospectively evaluated 263 patients (142 male, 121 female, mean age: 44 years, range: 16-89 years) with miliary TB. Criteria for the diagnosis of miliary TB were at least one of the followings in the presence of clinical presentation suggestive of miliary TB such as prolonged fever, night sweats, anorexia, weight loss: Radiologic criterion and pathological criterion and/or microbiological criterion; pathological criterion and/or microbiological criterion. The miliary pattern was seen in 88% of the patients. Predisposing factors were found in 41% of the patients. Most frequent clinical features and laboratory findings were fever (100%), fatigue (91%), anorexia (85%), weight loss (66%), hepatomegaly (20%), splenomegaly (19%), choroid tubercules (8%), anemia (86%), pancytopenia (12%), and accelerated erythrocyte sedimentation rate (89%). Tuberculin skin test was positive in 29% of cases. Fifty percent of the patients met the criteria for fever of unknown origin. Acid-fast bacilli were demonstrated in 41% of patients (81/195), and cultures for Mycobacterium tuberculosis were positive in 51% (148/292) of tested specimens (predominantly sputum, CSF, and bronchial lavage). Blood cultures were positive in 20% (19/97). Granulomas in tissue samples of liver, lung, and bone marrow were present in 100% (21/21), 95% (18/19), and 82% (23/28), respectively. A total of 223 patients (85%) were given a quadruple anti-TB treatment. Forty-four (17%) patients died within 1 year after diagnosis established. Age, serum albumin, presence of military pattern, presence of mental changes, and hemoglobin concentration were found as independent predictors of mortality. Fever resolved within first 21 days in the majority (90%) of the cases. Miliary infiltrates on chest X-ray should raise the possibility of miliary TB especially in countries where TB is endemic. Although biopsy of the lungs and liver may have higher yield rate of organ involvement histopathologicaly, less invasive procedures including a bone marrow biopsy and blood cultures should be preferred owing to low complication rates. © 2017 the Author(s). Published by Wolters Kluwer Health, Inc.

Drought in East Africa is a recurring phenomenon with significant humanitarian impacts. Given the steep climatic gradients, topographic contrasts, general data scarcity, and, in places, political instability that characterize the region, there is a need for spatially distributed, remotely derived monitoring systems to inform national and international drought response. At the same time, the very diversity and data scarcity that necessitate remote monitoring also make it difficult to evaluate the reliability of these systems. Here we apply a suite of remote monitoring techniques to characterize the temporal and spatial evolution of the 2010–2011 Horn of Africa drought. Diverse satellite observations allow for evaluation of meteorological, agricultural, and hydrological aspects of drought, each of which is of interest to different stakeholders. Focusing on soil moisture, we apply triple collocation analysis (TCA) to three independent methods for estimating soil moisture anomalies to characterize relative error between products and to provide a basis for objective data merging. The three soil moisture methods evaluated include microwave remote sensing using the Advanced Microwave Scanning Radiometer – Earth Observing System (AMSR-E) sensor, thermal remote sensing using the Atmosphere-Land Exchange Inverse (ALEXI) surface energy balance algorithm, and physically based land surface modeling using the Noah land surface model. It was found that the three soil moisture monitoring methods yield similar drought anomaly estimates in areas characterized by extremely low or by moderate vegetation cover, particularly during the below-average 2011 long rainy season. Systematic discrepancies were found, however, in regions of moderately low vegetation cover and high vegetation cover, especially during the failed 2010 short rains. The merged, TCA-weighted soil moisture composite product takes advantage of the relative strengths of each method, as judged by the consistency of anomaly estimates across independent methods. This approach holds potential as a remote soil moisture-based drought monitoring system that is robust across the diverse climatic and ecological zones of East Africa.

Drought in East Africa is a recurring phenomenon with significant humanitarian impacts. Given the steep climatic gradients, topographic contrasts, general data scarcity, and, in places, political instability that characterize the region, there is a need for spatially distributed, remotely derived monitoring systems to inform national and international drought response. At the same time, the very diversity and data scarcity that necessitate remote monitoring also make it difficult to evaluate the reliability of these systems. Here we apply a suite of remote monitoring techniques to characterize the temporal and spatial evolution of the 2010–2011 Horn of Africa drought. Diverse satellite observations allow for evaluation of meteorological, agricultural, and hydrological aspects of drought, each of which is of interest to different stakeholders. Focusing on soil moisture, we apply triple collocation analysis (TCA) to three independent methods for estimating soil moisture anomalies to characterize relative error between products and to provide a basis for objective data merging. The three soil moisture methods evaluated include microwave remote sensing using the Advanced Microwave Scanning Radiometer – Earth Observing System (AMSR-E) sensor, thermal remote sensing using the Atmosphere-Land Exchange Inverse (ALEXI) surface energy balance algorithm, and physically based land surface modeling using the Noah land surface model. It was found that the three soil moisture monitoring methods yield similar drought anomaly estimates in areas characterized by extremely low or by moderate vegetation cover, particularly during the below-average 2011 long rainy season. Systematic discrepancies were found, however, in regions of moderately low vegetation cover and high vegetation cover, especially during the failed 2010 short rains. The merged, TCA-weighted soil moisture composite product takes advantage of the relative strengths of each method, as judged by the consistency of anomaly estimates across independent methods. This approach holds potential as a remote soil moisture-based drought monitoring system that is robust across the diverse climatic and ecological zones of East Africa.

PubMed ID: 28151863 ; The aim of this study was to determine the clinical features, and outcome of the patients with miliary tuberculosis (TB). We retrospectively evaluated 263 patients (142 male, 121 female, mean age: 44 years, range: 16-89 years) with miliary TB. Criteria for the diagnosis of miliary TB were at least one of the followings in the presence of clinical presentation suggestive of miliary TB such as prolonged fever, night sweats, anorexia, weight loss: Radiologic criterion and pathological criterion and/or microbiological criterion; pathological criterion and/or microbiological criterion. The miliary pattern was seen in 88% of the patients. Predisposing factors were found in 41% of the patients. Most frequent clinical features and laboratory findings were fever (100%), fatigue (91%), anorexia (85%), weight loss (66%), hepatomegaly (20%), splenomegaly (19%), choroid tubercules (8%), anemia (86%), pancytopenia (12%), and accelerated erythrocyte sedimentation rate (89%). Tuberculin skin test was positive in 29% of cases. Fifty percent of the patients met the criteria for fever of unknown origin. Acid-fast bacilli were demonstrated in 41% of patients (81/195), and cultures for Mycobacterium tuberculosis were positive in 51% (148/292) of tested specimens (predominantly sputum, CSF, and bronchial lavage). Blood cultures were positive in 20% (19/97). Granulomas in tissue samples of liver, lung, and bone marrow were present in 100% (21/21), 95% (18/19), and 82% (23/28), respectively. A total of 223 patients (85%) were given a quadruple anti-TB treatment. Forty-four (17%) patients died within 1 year after diagnosis established. Age, serum albumin, presence of military pattern, presence of mental changes, and hemoglobin concentration were found as independent predictors of mortality. Fever resolved within first 21 days in the majority (90%) of the cases. Miliary infiltrates on chest X-ray should raise the possibility of miliary TB especially in countries where TB is endemic. Although biopsy of the lungs and liver may have higher yield rate of organ involvement histopathologicaly, less invasive procedures including a bone marrow biopsy and blood cultures should be preferred owing to low complication rates. © 2017 the Author(s). Published by Wolters Kluwer Health, Inc.

WOS: 000356799600005 ; PubMed ID: 25999021 ; Acute heart failure is a fatal syndrome. Emergency physicians, cardiologists, intensivists, nurses and other health care providers have to cooperate to provide optimal benefit. However, many treatment decisions are opinion-based and few are evidenced-based. This consensus paper provides guidance to practicing physicians and nurses to manage acute heart failure in the pre-hospital and hospital setting. Criteria of hospitalization and of discharge are described. Gaps in knowledge and perspectives in the management of acute heart failure are also detailed. This consensus paper on acute heart failure might help enable contiguous practice. ; Bayer; Cardiorentis; Medicine Company; Critical Diagnostics; Novartis; Steering Committee member of Cardiorentis; TUBITAK; Medicines Company; Cornerstone Therapeutics; Otsuka; Janssen; Apex Innovations; Inte-Section Medical; Trevena; Vifor Pharma Ltd; Amgen; Servier; Abbott Vascular; Coridea; Respicardia; Swiss National Science Foundation; Swiss Heart Foundation; Cardiovascular Research Foundation Basel; 8sense; Abbott; ALERE; Brahms; Nanosphere; Roche; Siemens; University Hospital Basel; Astra Zeneca; BG medicine; Biomerieux; Lilly; Orion; Resmed; Roche Diagnostics; Ratiopharm; BMS; Boehringer-Ingelheim; Pfizer; Daiichi Sankyo; Boehinger Ingelheim; AstraZeneca; European Union ; A.M. received speaker's honoraria from Alere, Bayer, Edwards Life Sciences, The Medicines Company, Novartis, Orion, Servier, Thermofisher, Vifor Pharma and also received fee as member of advisory board and/or Steering Committee from Bayer, Cardiorentis, The Medicine Company, Critical Diagnostics.; M.B.Y. received speaker's honoraria and research fee from Novartis and received fee as Steering Committee member of Cardiorentis, and is supported by TUBITAK.; P.L. received speaker's honoraria from Beckman Coulter and Novartis and also received fees as a member of advisory board and/or Steering Committee from Bayer, Cardiorentis, The Medicines Company, Cornerstone Therapeutics, Novartis, Otsuka, Janssen, Apex Innovations, Inte-Section Medical, and Trevena.; P.P. received speaker's honoraria from Bayer, Novartis, Servier, Vifor Pharma, Amgen, Pfizer, Cardiorentis, Merck-Serono, Abbott Vascular and Respicardia and also received fee as member of advisory board and/or Steering Committee from Bayer, Cardiorentis, Novartis, Vifor Pharma Ltd, Amgen, Servier, Abbott Vascular, Coridea and Respicardia.; E.L. received consultancy fee from Novartis.; J.M. received honoraria for speaker or advisor from Abbott, Novartis, Orion, Otsuka, and Sanofi and fee as a member of Steering Committee from Corthera, Novartis, and Cardiorentis.; C.M. received research grants from the Swiss National Science Foundation and the Swiss Heart Foundation, the Cardiovascular Research Foundation Basel, 8sense, Abbott, ALERE, Brahms, Critical Diagnostics, Nanosphere, Roche, Siemens, and the University Hospital Basel, as well as speaker/consulting honoraria from Astra Zeneca, Abbott, ALERE, BG medicine, Biomerieux, Brahms, Cardiorentis, Lilly, Novartis, Pfizer, Roche, and Siemens.; V.P.H. received speaker's fee: Bayer, Orion, Resmed, Roche Diagnostics, Ratiopharm; consultation fees: Bayer, BMS, Boehringer-Ingelheim, Novartis, Pfizer, Roche Diagnostics, Servier. H.A.T. received speaker's honoraria from Daiichi Sankyo, Lilly, Medicines Company, AstraZeneca, Boehinger Ingelheim. Advisory board for Maquet Cardiovascular. Institutional research support by Maquet Cardiovascular, Teleflex, Terumo, Lilly, The Medicine Company.; G.F. has received research grants and/or has served as Committee member or Cochair of studies sponsored by Bayer, Novartis, Cardiorentis, Vifor Pharma, and the European Union.

EU ; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) of Austria ; Russian Foundation for Basic Research (RFBR) ; Fundação para a Ciência e a Tecnologia (FCT) ; FCT ; MEC ; FEDER ; DURSI ; European Union ; Spanish MCYT ; Junta de Andaluc a ; CICYT ; APART ; European Community through a Marie Curie Fellowship ; MEC Ramon y Cajal ; Science and Technology Facilities Council (STFC) ; Fermi Research Alliance ; LLC ; Belgian Federal Science Policy ; RFFI ; Bundesministerium für Bildung und Forschung (BMBF) ; EU: MRTN-CT2004-503369 ; EU: MRTN-CT-2006-035505 ; EU: HPRN-CT-2000149 ; EU: HPRN-CT-2000-00152 ; EU: MRTN-CT-2006-035482 ; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) of Austria: P18959-N16 ; RFBR: 07-02-00256 ; Fundação para a Ciência e Tecnologia (FCT): SFRH/BD/13936/2003 ; Fundação para a Ciência e Tecnologia (FCT): SFRH/BD/18762/2004 ; FCT: POCI/FIS/59741/2004 ; FCT: SFRH/BPD/5575/2001 ; FCT: SFRH/BPD/23427/2005 ; FEDER: 2004-04582-C02-01 ; DURSI: 2005SGR00564 ; DURSI: 2001SGR-00188 ; European Union: MEIF-CT2003-500030 ; Spanish MCYT: FPA2003-09298-C02-01 ; Junta de Andaluc a: FQM-101 ; CICYT: FPA2002- 00648 ; LLC: DE-AC0207CH11359 ; Belgian Federal Science Policy: IAP 6/11 ; RFFI: N 07-02-00256 ; German Ministry of Education and Research (BMBF): 05HT6WWA ; This chapter of the "Flavor in the era of LHC" workshop report discusses flavor-related issues in the production and decays of heavy states at the LHC at high momentum transfer Q, both from the experimental and the theoretical perspective. We review top quark physics, and discuss the flavor aspects of several extensions of the standard model, such as supersymmetry, little Higgs models or models with extra dimensions. This includes discovery aspects, as well as the measurement of several properties of these heavy states. We also present publicly available computational tools related to this topic.

We thank CERN for the very successful operation of the LHC, as well as the support staff from our institutions without whom ATLAS could not be operated efficiently. We acknowledge the support of ANPCyT, Argentina; YerPhI, Armenia; ARC, Australia; BMWFW and FWF, Austria; ANAS, Azerbaijan; SSTC, Belarus; CNPq and FAPESP, Brazil; NSERC, NRC and CFI, Canada; CERN; CONICYT, Chile; CAS, MOST and NSFC, China; COLCIENCIAS, Colombia; MSMT CR, MPO CR and VSC CR, Czech Republic; DNRF, DNSRC and Lundbeck Foundation, Denmark; IN2P3–CNRS, CEA-DSM/IRFU, France; GNSF, Georgia; BMBF, HGF, and MPG, Germany; GSRT, Greece; RGC, Hong Kong SAR, China; ISF, I-CORE and Benoziyo Center, Israel; INFN, Italy; MEXT and JSPS, Japan; CNRST, Morocco; FOM and NWO, Netherlands; RCN, Norway; MNiSW and NCN, Poland; FCT, Portugal; MNE/IFA, Romania; MES of Russia and NRC KI, Russian Federation; JINR; MESTD, Serbia; MSSR, Slovakia; ARRS and MIZŠ, Slovenia; DST/NRF, South Africa; MINECO, Spain; SRC and Wallenberg Foundation, Sweden; SERI, SNSF and Cantons of Bern and Geneva, Switzerland; MOST, Taiwan; TAEK, Turkey; STFC, United Kingdom; DOE and NSF, United States of America. In addition, individual groups and members have received support from BCKDF, the Canada Council, CANARIE, CRC, Compute Canada, FQRNT, and the Ontario Innovation Trust, Canada; EPLANET, ERC, FP7, Horizon 2020 and Marie Skłodowska-Curie Actions, European Union; Investissements d'Avenir Labex and Idex, ANR, Region Auvergne and Fondation Partager le Savoir, France; DFG and AvH Foundation, Germany; Herakleitos, Thales and Aristeia programmes co-financed by EU-ESF and the Greek NSRF; BSF, GIF and Minerva, Israel; BRF, Norway; the Royal Society and Leverhulme Trust, United Kingdom. The crucial computing support from all WLCG partners is acknowledged gratefully, in particular from CERN and the ATLAS Tier-1 facilities at TRIUMF (Canada), NDGF (Denmark, Norway, Sweden), CC-IN2P3 (France), KIT/GridKA (Germany), INFN-CNAF (Italy), NL-T1 (Netherlands), PIC (Spain), ASGC (Taiwan), RAL (UK) and BNL (USA) and in the Tier-2 facilities worldwide.

We thank CERN for the very successful operation of the LHC, as well as the support staff from our institutions without whom ATLAS could not be operated efficiently. We acknowledge the support of ANPCyT, Argentina; YerPhI, Armenia; ARC, Australia; BMWFW and FWF, Austria; ANAS, Azerbaijan; SSTC, Belarus; CNPq and FAPESP, Brazil; NSERC, NRC and CFI, Canada; CERN; CONICYT, Chile; CAS, MOST and NSFC, China; COLCIENCIAS, Colombia; MSMT CR, MPO CR and VSC CR, Czech Republic; DNRF, DNSRC and Lundbeck Foundation, Denmark; EPLANET, ERC and NSRF, European Union; IN2P3-CNRS, CEA-DSM/IRFU, France; GNSF, Georgia; BMBF, DFG, HGF, MPG and AvH Foundation, Germany; GSRT and NSRF, Greece; RGC, Hong Kong SAR, China; ISF, MINERVA, GIF, I-CORE and Benoziyo Center, Israel; INFN, Italy; MEXT and JSPS, Japan; CNRST, Morocco; FOM and NWO, Netherlands; BRF and RCN, Norway; MNiSW and NCN, Poland; GRICES and FCT, Portugal; MNE/IFA, Romania; MES of Russia and NRC KI, Russian Federation; JINR; MSTD, Serbia; MSSR, Slovakia; ARRS and MIZS, Slovenia; DST/NRF, South Africa; MINECO, ˇ Spain; SRC and Wallenberg Foundation, Sweden; SER, SNSF and Cantons of Bern and Geneva, Switzerland; NSC, Taiwan; TAEK, Turkey; STFC, the Royal Society and Leverhulme Trust, United Kingdom; DOE and NSF, United States of America. The crucial computing support from all WLCG partners is acknowledged gratefully, in particular from CERN and the ATLAS Tier-1 facilities at TRIUMF (Canada), NDGF (Denmark, Norway, Sweden), CC-IN2P3 (France), KIT/GridKA (Germany), INFN-CNAF (Italy), NL-T1 (Netherlands), PIC (Spain), ASGC (Taiwan), RAL (U.K.) and BNL (U.S.A.) and in the Tier-2 facilities worldwide.